> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Biosimilar User Fee Rates for FY 2018
- URL: https://www.fdaweb.com/biosimilar-user-fee-rates-for-fy-2018/
- Published: 2017-09-14T12:00:00.000Z
- Updated: 2026-09-14T22:50:12.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139634

*Federal Register* notice: FDA has announced rates for biosimilar user fees for fiscal year (FY) 2018\. The agency is authorized to assess and collect user fees for certain activities in connection with biosimilar biological product development (BPD); review of certain applications for approval of biosimilar biological products; and each biosimilar biological product approved in a biosimilar application. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-09-14/pdf/2017-19493.pdf?ref=fdaweb.com).